Woman's World on MSN
Estrogen patch shortage? Don't panic-try these doctor-backed swaps
Menopause is not a time to stress. But we understand that the recent shortage of hormone replacement therapy (HRT) patches ...
Athira Pharma has joined an attempt to rescue an asset abandoned by Pfizer. The biotech has secured near-global rights to a phase 3 breast cancer prospect in a deal with Sermonix Pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results